Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Our aim was to evaluate the efficacy and safety of cisplatin with pemtrexed or vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT). Patients with unresectable stage III non-small-cell lung cancer (NSCLC) were randomly assigned to two regimens. The experimental...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Zhao, Qian, Wang, Zhongtang, Huang, Wei, Wang, Qiang, Yu, Shuzeng, Zhou, Tao, Han, Dan, Wu, Zhenying, Gong, Heyi, Sun, Hongfu, Zhang, Jian, Wei, Yumei, Li, Hongsheng, Zhang, Zicheng, Lin, Haiqun, Li, Baosheng
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Clinical Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://ncbi.nlm.nih.gov/pubmed/26761213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6871
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы